CAREGEN CO.,LTD. Logo

CAREGEN CO.,LTD.

Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.

214370 | KO

Overview

Corporate Details

ISIN(s):
KR7214370009
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 엘에스로91번길 46-38, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Caregen Co., Ltd., established in 2001, is a global biotechnology company specializing in the research, development, and commercialization of biomimetic peptides and growth factors. As a leader in peptide synthesis, the company leverages its proprietary platform technologies and an extensive portfolio of patented peptides. Caregen develops and manufactures innovative products, including cosmeceuticals and dermal fillers, for the medical aesthetics and pharmaceutical markets. Its core research focuses on applications such as anti-aging solutions and hair regrowth treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 54.0 KB
2025-09-08 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 38.5 KB
2025-08-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 11.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-12 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-08-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-08-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.3 KB
2025-07-15 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 10.6 KB
2025-07-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.6 KB
2025-06-26 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계…
Korean 25.2 KB
2025-06-13 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.7 KB
2025-05-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-13 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all CAREGEN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAREGEN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAREGEN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea
311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea
063160
Clearmind Medicine Inc. Logo
Develops psychedelic-derived medicines for Alcohol Use Disorder and mental health conditions.
United States of America
CMND
Clearside Biomedical, Inc. Logo
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
United States of America
CLSD
Clene Inc. Logo
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
United States of America
CLNN
Climb Bio, Inc. Logo
Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.
United States of America
CLYM
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea
058820
Cocrystal Pharma, Inc. Logo
Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.
United States of America
COCP
Co-Diagnostics, Inc. Logo
Develops patented PCR solutions for accurate infectious disease diagnostics.
United States of America
CODX
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany
CNW

Talk to a Data Expert

Have a question? We'll get back to you promptly.